VivoSeq
Oncology

Stage II Colon Cancer

1

Pipeline Programs↗

3

Active Trials↗

1

Companies Involved↗

Stage II Colon Cancer is an early-stage landscape with 1 program across 1 company. The most active players are Roche. 1 program is in Phase 3.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

67/100

Attrition Rate

13/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Roche logo

Roche

1 program

Phase 3

Pipeline

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 31

Mfolfox6

Roche

Approved
No programs

Analysis

Trial Status

8

clinical trials

Completed2 · 25%
Unknown status2 · 25%
Not yet recruiting1 · 13%
Terminated1 · 13%
Active, not recruiting1 · 13%
Recruiting1 · 13%

Clinical Trials

Trial Activity

8 trials

CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II
Recruiting·CCentre Hospitalier Universitaire Dijon·Phase 3·NCT04120701·1,980 enrolled
Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
Active, not recruiting·National Cancer Institute (NCI)·Phase 3·NCT00217737·2,431 enrolled
A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer
Not yet recruiting·VVaccinogen Inc·Phase 3·NCT02448173·550 enrolled
Edrecolomab in Treating Patients With Stage II Colon Cancer
Completed·National Cancer Institute (NCI)·Phase 3·NCT00002968·2,100 enrolled
Identifying Prognostic Factors in Patients Receiving Tegafur-Uracil for Stage II Colon Cancer That Was Completely Removed By Surgery
Completed·TTranslational Research Center for Medical Innovation, Kobe, Hyogo, Japan·N/A·NCT00898846·1,111 enrolled
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Terminated·NNSABP Foundation Inc·Phase 3·NCT01011478·406 enrolled
Post-surgical Liquid Biopsy-guided Treatment of Stage III and High-risk Stage II Colon Cancer Patients: the PEGASUS Trial
Unknown status·IIFOM ETS - The AIRC Institute of Molecular Oncology·Phase 2·NCT04259944·140 enrolled
Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
Unknown status·FFederation Francophone de Cancerologie Digestive·Phase 3·NCT00091312·1,976 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)